MAX-40279 Uses, Dosage, Side Effects and more
MAX-40279 is under investigation in clinical trial NCT03412292 (MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)).
Trade Name | MAX-40279 |
Generic | MAX-40279 |
Type | |
Formula | C22H23FN6OS |
Weight | Average: 438.53 Monoisotopic: 438.163808722 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |